Navigation Links
Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
Date:1/27/2009

ROCKVILLE, Md. and NEW YORK, Jan. 27 /PRNewswire-USNewswire/ -- Researchers from the J. Craig Venter Institute (JCVI) and the Ludwig Institute for Cancer Research (LICR) have uncovered new genomic alterations that lead to gene fusions in a breast cancer cell line by using 454 Life Sciences sequencing technology. The work, led by Qi Zhao of JCVI and Otavia L. Caballero, of LICR, is being published the week of January 26 in the early online edition of the Journal of the Proceedings of the National Academy of Sciences (PNAS).

Previous studies have shown that gene fusions are key gene alteration events in the development and progression of many kinds of cancers. The discovery of the best known gene fusion, BCR-ABL, led to the development of Gleevec(R) for the treatment of chronic myelogenous leukemia and other cancers.

In this proof of concept study the researchers focused on the transcriptome, a subset of genes in the genome that code for proteins. It has long been known that cancers arise from various types of genomic changes in certain cells. Continued advances and cost efficiencies of next generation DNA sequencing technologies are enabling this more precise and detailed examination of changes in the human genome that could be directly involved in cancer.

The JCVI/LICR researchers began with a well-characterized breast cancer cell line, HCC1954 and performed high-throughput transcriptome sequencing. Previous studies on this cell line have uncovered certain types of genetic mutations and chromosomal abnormalities associated with breast cancer. By conducting the in-depth transcript sequencing in this study and comparing these data to the previous studies a clearer picture is emerging of all the expressed genes some of which present in altered forms in the cancer cell line.

The team began by generating more than half a million 454 reads of cDNA sequences. After extensive data
'/>"/>

SOURCE J. Craig Venter Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Research Suggests Platelet Stickiness May be the Single Most Important Risk Factor in Patients Treated with Coronary Stents - Findings May be Applicable to Anyone with Vascular Disease
2. Why Wait for an Anti-Aging Drug? Researchers Interviewed on CBS-TVs 60 MINUTES Discover Longevinex(R) Nutriceutical Matrix Activates 9-Fold More Longevity Genes than Plain Resveratrol
3. Phidea Srl and Marvin Research Srl Announce Completion of Merger
4. Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research
5. Inclinix Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment
6. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
7. WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System
8. Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinsons Disease Research
9. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
10. 2008 Human Research Protection Award Recipients Announced
11. New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...Dec. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (...ical products in China, announced today that,it ha...vaccine, PANFLU.1(TM),from China,s Ministry of In...,purchase plan. Under this purchase order, Sinovac...doses of PANFLU.1 (TM) (15ug/0.5ml) for the Chines...
(Date:12/1/2009)...ec. 1 Sagent Pharmaceuticals, Inc....y, today announced the launch of two antibiotics: ...njection, USP. Both are antibiotics of the cephalo...ive and gram-negative bacteria. Sagent will launch...ent the four vial sizes launched by Sagent in July...
(Date:12/1/2009)...lif., Dec. 1 Codexis, Inc. today a...signing of its second agreement this year with Tev...est generic drug manufacturer. The new agreement ... Codexis announced an earlier agreement with Teva ...will use Codexis biocatalysis technology for key p...
Breaking Medicine Technology:Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Codexis Expands Collaboration with Teva 2Tips To Enjoy a Flu Free Holiday Season 62071 1Tips To Enjoy a Flu Free Holiday Season 62071 2Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 1Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 62067 2Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 1Union Labor Life 26amp 3B VSP Vision Care Align to Offer Vision Insurance Products 62063 2
...I) (Nasdaq and MTA: CTIC) announced that data from...pixantrone in patients with advanced, relapsed agg...nted at the 2009 American Society of Clinical Onco...m May 29 to June 2, 2009 in Orlando, Florida. , ,...niversity of London, an investigator on the study,...
...(Nasdaq: SPEX ), an innovator in biotechnology f...nd regulatory consulting services to food, supplem...oday announced that, on May 12, 2009, its Board of...omas B. Peter, to begin serving immediately. Mr. ...n and Nominating Committees. , , Spherix,s Nomina...
Other Medicine Technology:Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 2Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting 3Spherix Elects New Independent Director, and Elects Chairman of the Board 2Spherix Elects New Independent Director, and Elects Chairman of the Board 3
(Date:12/1/2009)...INE, Calif., Dec. 1 Mas...imetry(TM) and Measure-Through Motion and Low Perf...e of its latest innovation -- Masimo Rainbow SET A...and continuous respiration rate (RRa(TM)) that is ...ance. Masimo Rainbow SET Acoustic Monitoring may ...
(Date:12/1/2009)... Craig Moskowitz, a fourth-year medical student at...o go into internal medicine to help fulfill an unm...k, NJ (PRWEB) December 1, 2009 -- Having distingui...censing examinations, Craig Moskowitz--a fourth-ye...dicine--knew he could go into any area of medicine...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)... Dec. 1 "The patient will see you ...Blue Cross and Blue Shield of Minnesota,s 10,000 e...rst Minnesotans - and the first in the continental.... Online Care Anywhere allows patients to access m...to a computer or picking up the phone. Blue Cross ...
(Date:12/1/2009)...tion from annual mammography screening may increas...lial predisposition to breast cancer, according to...the Radiological Society of North America (RSNA). ...reening is very important, but a careful approach ...creening young women, particularly under age 30," ...
Breaking Medicine News(10 mins):Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3Health News:Mammography may increase breast cancer risk in some high-risk women 2
...., Jan. 12 Alseres Pharmaceuticals, Inc. today a...ce from the NASDAQ Stock Market ("NASDAQ") that fo... value of its listed securities has been below the... comply with NASDAQ Marketplace Rule 4310(c)(3)(A)...
...w Have Access to Advanced Medical Expertise When F... NEW YORK, Jan. 12 Nippon Life Benefits, a leadin...ompanies, today announced that its members will ha... , , The new service will allow eligible employe...
... Va., Jan. 12, 2009 AMERIGROUP Corporation (NYSE:...he AMERIGROUP Public Policy Institute, which will ...althcare programs and initiatives that serve peopl...of AMERIGROUP Corporation and the AMERIGROUP Found...
... Affiliated Computer Services, Inc. (NYSE: ACS ...h Health Savings Account (HSA) administration serv...lect counties of Washington. Regence members will .../Intermountain region, ACS now offers the ACS HSA ...
...The Netherlands, January 12 , - Small and Com...care and,Hospitality , With the introduction o...nd easily wearable wireless messaging device, NEC ...com.com/cgi-bin/prnh/20090112/333834 ) , The ...
...ne, the only publication of its kind aimed at heal...12 HealthCare Insight(R) (HCI), a Verisk HealthCa...fraud, abuse, and overpayment prevention solutions...rehensive publication dedicated to helping public ...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 2Health News:Nippon Life Benefits Partners with Best Doctors to Help Members Make More Informed Health Care Decisions 3Health News:AMERIGROUP to Establish Public Policy Institute 2Health News:AMERIGROUP to Establish Public Policy Institute 3Health News:ACS to Provide HSA Product to Regence; ACS HSA Solution Now Offered by Blue Cross Blue Shield Plans in 28 States 2Health News:NEC's new M155 Messenger Sets New Standards in Mobile Messaging 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2
Legionella IgG/M II ELISA
Epstein-Barr virus (EBV) ELISA
HSV Group IgG ELISA
CMV IgG II ELISA
Medicine Products: